Press Releases

Date	Title and Summary	Additional Formats
May 31, 2018	Vericel Corporation Prices $65 Million Public Offering of Common Stock	View HTML PDF Version
May 30, 2018	Vericel Corporation Announces Proposed Public Offering of Common Stock	View HTML PDF Version
May 25, 2018	Vericel to Present at the Jefferies 2018 Global Healthcare Conference	View HTML PDF Version
May 8, 2018	Vericel Reports First Quarter 2018 Financial Results	View HTML PDF Version
April 24, 2018	Vericel to Report First-Quarter 2018 Financial Results on May 8, 2018	View HTML PDF Version
April 10, 2018	Vericel to Present at the 6th Annual Cell & Gene Therapy Investor Day	View HTML PDF Version
March 23, 2018	Vericel Reports Publication of Results from the Phase 3 SUMMIT Extension Study Demonstrating Sustained Clinical Benefit of MACI Out to Five Years	View HTML PDF Version
March 13, 2018	Vericel to Present at the 17th Annual Needham Healthcare Conference	View HTML PDF Version
March 12, 2018	Vericel to Host Analyst and Investor Day on April 11, 2018	View HTML PDF Version
March 9, 2018	Vericel to Present at BioCentury’s 25th Annual Future Leaders in the Biotech Industry Conference	View HTML PDF Version

Investor Relations